AzTrials
AzTrials

Hip FractureNCT02037633

Analgesia for Positioning Hip Fracture Patients for Spinal Anesthesia

A study testing Fentanyl, Fascia iliaca compartment block and ropivacaine in people with Hip Fracture, run by Asklepieion Voulas General Hospital at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare two analgesic methods performed preoperatively to assist positioning patients for performance of spinal anesthesia, namely fascia iliaca blockade and intravenous fentanyl. Read more about this study

Who is it for?
Any age
Conditions the study is for
Hip Fracture
What is being tested?
Fentanyl, Fascia iliaca compartment block and ropivacaine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteGreece
Study dates
Jul 2012to Feb 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Hip fracture

Who cannot join

  • contraindications for central nervous blockade
  • impaired cognition or dementia
  • multiple fractures
  • any previous analgesic administration during the last 12 hours

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Asklepieion Hospital of Voula

    Athens, Attica, 16673

Other trials in Greece

About this study

Official title: Fascia Iliaca Compartment Block Versus Fentanyl for Positioning Patients With Hip Fractures for Central Nervous Blockade: a Randomized Trial.

The purpose of this study is to compare two analgesic methods performed preoperatively to assist positioning patients for performance of spinal anesthesia, namely fascia iliaca blockade and intravenous fentanyl.

Conditions
Hip Fracture
Being tested
Fentanyl, Fascia iliaca compartment block, ropivacaine
Medical subject headings
Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FentanylDrug

    Fentanyl IV

  • Fascia iliaca compartment blockProcedure or surgery

    Fascia iliaca compartment block using ropivacaine

  • ropivacaineDrug

Study groups in NCT02037633
Study groupRoleWhat they receive
Fascia iliaca compartment blockActive comparatorNot described
Receives: Procedure: Fascia iliaca compartment block; Drug: ropivacaine
FentanylActive comparatorNot described
Receives: Drug: Fentanyl

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain scores on the Numeric Rating Scale

    Measured: Group A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)

Secondary outcomes (2)
  1. Duration of spinal anesthesia performance

    It will be measured in "minutes", from the start of positioning maneuvers to the spinal needle removal

    Measured: Group A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)

  2. Quality of patient's position

    The position will be characterized as "unsatisfactory", "satisfactory", "good" or "very good"

    Measured: Group A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2014 (estimated)
  2. Study startJul 2012
  3. Primary completionFeb 2013
  4. Study completionFeb 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02037633
Sponsor's protocol ID
478-9227/25-7-2012
Status last verified
Jan 2014
First submitted
12 Jan 2014
Last updated
16 Jan 2014
Results posted
No
Data monitoring committee
No

Publications

  • Yun MJ, Kim YH, Han MK, Kim JH, Hwang JW, Do SH. Analgesia before a spinal block for femoral neck fracture: fascia iliaca compartment block. Acta Anaesthesiol Scand. 2009 Nov;53(10):1282-7. doi: 10.1111/j.1399-6576.2009.02052.x. Epub 2009 Jul 22.

    PubMed 19650803
  • Hogh A, Dremstrup L, Jensen SS, Lindholt J. Fascia iliaca compartment block performed by junior registrars as a supplement to pre-operative analgesia for patients with hip fracture. Strategies Trauma Limb Reconstr. 2008 Sep;3(2):65-70. doi: 10.1007/s11751-008-0037-9. Epub 2008 Sep 2.

    PubMed 18762870
  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

    PubMed 33238043

Questions about this trial

What is this clinical trial studying?

A study testing Fentanyl, Fascia iliaca compartment block and ropivacaine in people with Hip Fracture, run by Asklepieion Voulas General Hospital at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain scores on the Numeric Rating Scale (time frame: Group A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02037633, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in